Abstract
May-Hegglin anomaly1,2 (MHA) is an autosomal dominant macrothrombocytopenia of unclear pathogenesis characterized by thrombocytopenia, giant platelets and leukocyte inclusions. Studies have indicated that platelet structure and function are normal3,4,5,6,7, suggesting a defect in megakaryocyte fragmentation8. The disorder has been linked to chromosome 22q12–13. Here we screen a candidate gene in this region, encoding non-muscle myosin heavy chain A (MYH9), for mutations in ten families. In each family, we identified one of three sequence variants within either the α-helical coiled coil or the tailpiece domain that co-segregated with disease status. The E1841K mutation was found in 5 families and occurs at a conserved site in the rod domain. This mutation was not found in 40 normal individuals. Four families had a nonsense mutation that resulted in truncation of most of the tailpiece. One family had a T1155I mutation present in an affected mother and daughter, but not in the mother's parents, thus representing a new mutation. Among the 30 affected individuals, 21 unaffected individuals and 13 spouses in the 10 families, there was correlation of a variant of MYH9 with the presence of MHA. The identification of MYH9 as the disease gene for MHA establishes the pathogenesis of the disorder, should provide further insight into the processes of normal platelet formation and may facilitate identification of the genetic basis of related disorders.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
May, R. Leukozyteneinschlüsse. Dtsch. Arch. Klin. Med. 96, 1–6 (1909).
Hegglin, R. Gleichzeitige konstitutionelle Veränderungen an Neutrophilen und Thrombozyten. Helv. Med. Acta 12, 439–440 (1945).
Noris, P., Spedini, P., Belletti, S., Magrini, U. & Balduini, C.L. Thrombocytopenia, giant platelets, and leukocyte inclusion bodies (May-Hegglin anomaly): clinical and laboratory findings. Am. J. Med. 104, 355–360 (1998).
Coller, B.S. & Zarrabi, M.H. Platelet membrane studies in the May-Hegglin anomaly. Blood 58, 279–284 (1981).
Ricci, G., Manservigi, R., Albonici, L., Zavagli, G. & Cassai, E. Evidence for glycoprotein abnormality in platelets from patients with May-Hegglin anomaly. Thromb. Haemost. 54, 862–865 (1985).
Lusher, J.M., Schneider, J., Mizukami, I. & Evans, R.K. The May-Hegglin anomaly: platelet function, ultrastructure and chromosome studies. Blood 32, 950–961 (1968).
Hamilton, R.W. et al. Platelet function, ultrastructure, and survival in the May-Hegglin anomaly. Am. J. Clin. Pathol. 74, 663–668 (1980).
Godwin, H.A. & Ginsburg, A.D. May-Hegglin anomaly: a defect in megakaryocyte fragmentation? Br. J. Haematol. 26, 117–128 (1974).
Kelley, M.J. et al. Autosomal dominant macrothrombocytopenia with leukocyte inclusions (May-Hegglin anomaly) is linked to chromosome 22q12–13. Hum. Genet. 106, 557–564 (2000).
Kunishima, S. et al. Mapping of a gene for May-Hegglin anomaly to chromosome 22q. Hum. Genet. 105, 379–383 (1999).
Martignetti, J.A. et al. The gene for May-Hegglin anomaly localizes to a 1-Mb region on chromosome 22q12.3–13.1. Am. J. Hum. Genet. 66, 1449–1454 (2000).
McLachlan, A.D. & Karn, J. Periodic charge distributions in the myosin rod amino acid sequence match cross-bridge spacings in muscle. Nature 299, 226–231 (1982).
Moores, S.L. & Spudich, J.A. Conditional loss-of-myosin-II-function mutants reveal a position in the tail that is critical for filament nucleation. Mol. Cell 1, 1043–1050 (1998).
Hodge, T.P., Cross, R. & Kendrick-Jones, J. Role of the COOH-terminal nonhelical tailpiece in the assembly of a vertebrate nonmuscle myosin rod. J. Cell Biol. 118, 1085–1095 (1992).
Cripps, R.M., Suggs, J.A. & Bernstein, S.I. Assembly of thick filaments and myofibrils occurs in the absence of the myosin head. EMBO J. 18, 1793–1804 (1999).
Weiss, A., Schiaffino, S. & Leinwand, L.A. Comparative sequence analysis of the complete human sarcomeric myosin heavy chain family: implications for functional diversity. J. Mol. Biol. 290, 61–75 (1999).
Conrad, A.H., Jaffredo, T. & Conrad, G.W. Differential localization of cytoplasmic myosin II isoforms A and B in avian interphase and dividing embryonic and immortalized cardiomyocytes and other cell types in vitro. Cell Motil. Cytoskeleton 31, 93–112 (1995).
Maupin, P., Phillips, C.L., Adelstein, R.S. & Pollard, T.D. Differential localization of myosin-II isozymes in human cultured cells and blood cells. J. Cell. Sci. 107, 3077–3090 (1994).
Kolega, J. Cytoplasmic dynamics of myosin IIA and IIB: spatial ‘sorting’ of isoforms in locomoting cells. J. Cell Sci. 111, 2085–2095 (1998).
Kelley, C.A. et al. Xenopus nonmuscle myosin heavy chain isoforms have different subcellular localizations and enzymatic activities. J. Cell Biol. 134, 675–687 (1996).
De Lozanne, A. & Spudich, J.A. Disruption of the Dictyostelium myosin heavy chain gene by homologous recombination. Science 236, 1086–1091 (1987).
Knecht, D.A. & Loomis, W.F. Antisense RNA inactivation of myosin heavy chain gene expression in Dictyostelium discoideum. Science 236, 1081–1086 (1987).
Redowicz, M.J. Myosins and deafness. J. Muscle Res. Cell Motil. 20, 241–248 (1999).
Willems, P.J. Genetic causes of hearing loss. N. Engl. J. Med. 342, 1101–1109 (2000).
Dunham, I. et al. The DNA sequence of human chromosome 22. Nature 402, 489–495 (1999).
Ciulla, T.A., Sklar, R.M. & Hauser, S.L. A simple method for DNA purification from peripheral blood. Anal. Biochem. 174, 485–488 (1988).
The May-Hegglin/Fechtner Syndrome Consortium Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. Nature Genet. 26, 105–107 (2000).
Acknowledgements
We thank S. Li, M. Adkins, B. Weinberg, and the subjects and their physicians.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kelley, M., Jawien, W., Ortel, T. et al. Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly. Nat Genet 26, 106–108 (2000). https://doi.org/10.1038/79069
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/79069
This article is cited by
-
Whole-exome sequencing reveals known and novel variants in a cohort of intracranial vertebral–basilar artery dissection (IVAD)
Journal of Human Genetics (2018)
-
A case of MYH9 disorders caused by a novel mutation (p.K74E)
Annals of Hematology (2016)
-
Genetic testing in renal disease
Pediatric Nephrology (2012)
-
A large family with MYH9 disorder caused by E1841K mutation suffering from serious kidney and hearing impairment and cataracts
Annals of Hematology (2012)
-
Renal manifestations of patients with MYH9-related disorders
Pediatric Nephrology (2011)